Regulatory Process, Documentation, Timelines & Compliance
By Taj Pharma India Ltd.
Azerbaijan is an important and fast-growing pharmaceutical market in the CIS region. To legally import, distribute, and market external (topical) non-sterile pharmaceutical preparations such as creams, ointments, gels, lotions, and topical solutions, prior product registration and marketing authorization is mandatory.
Taj Pharma India Ltd., a WHO-GMP and EU-GMP compliant Indian pharmaceutical manufacturer, provides comprehensive regulatory and documentation support for successful registration of topical formulations in Azerbaijan.
Regulatory Authority in Azerbaijan
Pharmaceutical product registration in Azerbaijan is governed by the:
Ministry of Health of the Republic of Azerbaijan
through the Analytical Expertise Center (AEC)
The AEC is responsible for:
- Evaluation of quality, safety, and efficacy
- Registration and re-registration of medicinal products
- Regulatory review of imported pharmaceuticals
- Verification of GMP compliance
Only products granted Marketing Authorization may be legally marketed in Azerbaijan.
Product Scope – External Preparations
External preparations are regulated as medicinal products when they carry therapeutic or preventive claims.
Covered non-sterile dosage forms include:
- Creams
- Ointments
- Gels
- Lotions
- Topical solutions and suspensions
- Pastes
Products with purely cosmetic claims fall under separate cosmetic regulations and require a different approval pathway.
Eligibility & Applicant Requirements
- Foreign manufacturers may register products in Azerbaijan
- Applications must be submitted through a locally registered Marketing Authorization Holder (MAH)
- The MAH acts as the regulatory representative before the Ministry of Health
Taj Pharma supports partners with export-ready regulatory dossiers aligned with Azerbaijan requirements.
Registration Process for External Preparations
1. Appointment of Local MAH
A locally registered Azerbaijani entity is appointed as MAH to:
- Submit applications
- Coordinate with regulatory authorities
- Hold marketing authorization
2. Regulatory Dossier Preparation
The registration dossier is prepared in CTD or national format, generally in Azerbaijani or Russian, with technical documents in English where permitted.
Key dossier components include:
Administrative Documentation
- Application form
- Power of Attorney
- Manufacturer’s authorization letter
- Manufacturing license
- WHO-GMP / EU-GMP certificate
- Free Sale Certificate (FSC)
- Certificate of Pharmaceutical Product (CPP), if available
Quality & Technical Documentation
- Finished product specifications
- API and excipient specifications
- Manufacturing process and controls
- Batch Manufacturing Formula (BMF)
- Certificates of Analysis (API & Finished Product)
- Stability data (Zone IVb – hot and humid)
- Container closure system details
Safety & Efficacy Justification
- Literature-based safety and efficacy data
- Risk–benefit assessment for topical use
- Bibliographic references for well-established actives
Labeling & Packaging
- Primary and secondary packaging artwork
- Azerbaijani language labeling
- Package leaflet (where applicable)
- Storage conditions, shelf life, warnings, and usage instructions
3. Submission & Regulatory Review
- Dossier submission by MAH to the AEC
- Payment of official government fees
- Allocation of registration number
- Technical and scientific evaluation by the authority
Regulatory queries, if raised, must be addressed within defined timelines.
4. Sample Testing (If Applicable)
- The authority may request product samples
- Official laboratory testing may be conducted
- Reference standards may be required
5. Grant of Marketing Authorization
Upon successful evaluation, the Ministry of Health issues a Marketing Authorization Certificate.
Validity: Generally 5 years, subject to renewal.
Estimated Registration Timeline
| Stage | Typical Duration |
|---|---|
| Dossier preparation | 4–6 weeks |
| Regulatory review | 3–6 months |
| Query resolution | Case-dependent |
| Total timeline | 4–8 months |
Timelines may vary based on dossier quality and regulatory workload.
Registration Fees
Registration fees depend on:
- Product type and dosage form
- Number of strengths
- Scope of laboratory testing
Cost components typically include:
- Government evaluation fees
- Testing fees (if applicable)
- Translation and notarization costs
- Local MAH service charges
Official fees are determined by the Ministry of Health and may be revised periodically.
GMP & Compliance Requirements
Manufacturing sites must demonstrate:
- WHO-GMP or EU-GMP compliance
- Valid inspection reports
- Controlled quality management systems
- Ongoing regulatory and pharmacovigilance compliance
Taj Pharma’s manufacturing facilities are fully aligned with international GMP standards accepted in Azerbaijan.
Post-Approval Regulatory Obligations
After approval, the MAH must ensure:
- Timely renewal of marketing authorization
- Approval of variations (label, formulation, site, shelf life)
- Continuous compliance with approved specifications
- Market surveillance and complaint handling
Why Choose Taj Pharma for Azerbaijan Registration
- WHO-GMP, EU-GMP, PIC/S compliant facilities
- Strong expertise in non-sterile topical formulations
- CTD-ready dossiers for CIS and Eurasian markets
- Stability data suitable for Zone IVb climates
- End-to-end regulatory lifecycle support
- Export documentation and batch release assistance
Registration of external pharmaceutical preparations in Azerbaijan requires precise regulatory documentation, GMP compliance, and effective coordination with local authorities. With its proven regulatory capabilities and international manufacturing standards, Taj Pharma India Ltd. is a trusted partner for successful market entry and sustainable growth in Azerbaijan.
Contact for International Collaboration:
📧 Email: Sales@tajpharmaindia.com I Mumbai@tajpharma.com I Info@tajpharma.com
General Inquiry: +91 84484 44095 / 8071 555 357
WhatsApp:++91-7861865490/ 91-74 0000 9975 / 76
